![]() |
市場調查報告書
商品編碼
1684869
肺支架市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測Lung Stent Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球肺支架市場價值為 1.617 億美元,預計 2025 年至 2034 年期間將實現 9.3% 的強勁成長率。市場快速擴張可歸因於多種因素,包括慢性呼吸系統疾病盛行率上升、微創手術的進步以及旨在開發創新醫療技術的投資激增。由於空氣污染、吸煙和久坐的生活方式等因素,呼吸系統疾病變得越來越普遍。這些情況導致對肺支架的需求增加,因為它們對於因腫瘤、感染或先天性異常引起阻塞的患者維持氣道通暢和改善呼吸方面發揮著至關重要的作用。
肺支架因其透過提供有效的氣道管理解決方案來改善患者治療效果的能力而越來越受到認可。隨著醫療保健系統的發展,人們越來越傾向於採用微創治療,因為這種治療可以縮短恢復時間、減少併發症並降低醫療成本。技術進步使得肺支架能夠更適應各種氣道解剖結構,人工智慧驅動的成像和導航系統的整合進一步提高了支架放置的精準度。這種技術整合為更好的治療效果和成功率鋪平了道路。此外,全球人口老化更容易患上呼吸系統疾病,從而增加對此類醫療設備的需求。政府支持先進呼吸照護的舉措和優惠的報銷政策也推動了市場的成長。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 1.617 億美元 |
預測值 | 3.932億美元 |
複合年成長率 | 9.3% |
肺支架市場分為三種產品類型:氣管支架、支氣管支架和喉支架。氣管支架領域在 2024 年以 1.119 億美元的市場規模領先。氣管支架在治療嚴重氣道阻塞方面已被廣泛應用,成為醫療保健提供者中最受歡迎的選擇。這些支架可以在出現嚴重呼吸道阻塞的情況下立即緩解症狀,確保氣流不間斷,並顯著降低併發症的風險。因此,氣管支架通常用於緊急手術和計劃手術。
設備類型細分包括自膨脹支架和球囊膨脹支架。自膨脹支架領域在 2024 年創造了 1.265 億美元的收入,預計在 2025 年至 2034 年期間的複合年成長率為 9.4%。這些支架因其易於部署且能夠適應複雜的氣道結構而受到青睞。放置後,自膨脹支架會自動膨脹,從而縮短手術時間並確保準確定位。它們的可靠性和效率使得它們在快速恢復氣流至關重要的緊急情況下特別有價值。
在美國,肺支架市場在 2024 年達到 6,360 萬美元,預計到 2034 年將以 8.8% 的複合年成長率成長。由於美國擁有先進的醫療基礎設施、較高的肺部疾病發生率以及對微創治療的日益重視,美國將繼續主導全球市場。人工智慧成像等尖端技術的融合,提高了支架置入的精準度,進一步鞏固了中國在該領域的領先地位。政府的支持性政策和報銷框架也對美國市場的成長軌跡做出了重大貢獻。
The Global Lung Stent Market, valued at USD 161.7 million in 2024, is projected to experience a robust growth rate of 9.3% CAGR from 2025 to 2034. This rapid market expansion can be attributed to several factors, including the rising prevalence of chronic respiratory diseases, advancements in minimally invasive procedures, and a surge in investments aimed at developing innovative medical technologies. Respiratory conditions are becoming more widespread, driven by factors like air pollution, smoking, and sedentary lifestyles. These conditions have led to an increased demand for lung stents, as they play a crucial role in maintaining airway patency and improving breathing for patients suffering from blockages caused by tumors, infections, or congenital abnormalities.
Lung stents are increasingly recognized for their ability to improve patient outcomes by offering effective solutions for airway management. As healthcare systems evolve, there is a growing shift toward minimally invasive treatments that provide quicker recovery times, reduced complications, and lower healthcare costs. Technological advancements have made lung stents more adaptable to various airway anatomies, and the integration of artificial intelligence-driven imaging and navigation systems has further enhanced the precision of stent placement. This technological integration is paving the way for better treatment outcomes and success rates. Additionally, the aging global population is more vulnerable to respiratory diseases, contributing to a higher demand for such medical devices. Government initiatives supporting advanced respiratory care and favorable reimbursement policies are also fueling the market's growth.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $161.7 Million |
Forecast Value | $393.2 Million |
CAGR | 9.3% |
The lung stent market is divided into three product types: tracheal, bronchial, and laryngeal stents. The tracheal stents segment led the market with USD 111.9 million in 2024. Their widespread use in treating severe airway obstructions has made them the most preferred choice among healthcare providers. These stents offer immediate relief in cases of critical respiratory blockages, ensuring uninterrupted airflow and significantly reducing the risk of complications. As a result, tracheal stents are commonly used in both emergency and planned procedures.
Device type segmentation includes self-expandable and balloon-expandable stents. The self-expandable stents segment generated USD 126.5 million in 2024 and is expected to grow at a CAGR of 9.4% between 2025 and 2034. These stents are favored for their ease of deployment and their ability to conform to complex airway structures. Upon placement, self-expandable stents automatically expand, cutting down procedural time and ensuring accurate positioning. Their reliability and efficiency make them especially valuable in emergency scenarios where quick restoration of airflow is critical.
In the U.S., the lung stent market reached USD 63.6 million in 2024 and is anticipated to grow at a CAGR of 8.8% through 2034. The U.S. continues to dominate the global market, thanks to its advanced healthcare infrastructure, high incidence of lung diseases, and increasing focus on minimally invasive treatments. The integration of cutting-edge technologies, such as AI-driven imaging, is improving the precision of stent placements, further bolstering the country's leading position in this sector. Supportive government policies and reimbursement frameworks are also contributing significantly to the U.S. market's growth trajectory.